xrx2gr0 I think you may be stretching for negatives now. Yes an online newsletter included an incorrect attribution. OK.
I'm not worried about marketing versus the big boys. Or manufacturing. Or distribution. Those things will solve themselves as there will be ready queue of capable firms and experienced professionals eager to work with a small pharma with an approved drug for HD or AD. My concerns are purely about getting trials (HD, AD and PD) designed, funded and underway somewhere where they can be registered and move forward so we can get to that point.
SRPT Duchenne Drug trial hits 5 year mark, page-27
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $18.62M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $7.902K | 2.037M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 53603756 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 126995306 | 20 |
View Market Depth
| Last trade - 14.03pm 15/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |